Logo
X

Xilio Therapeutics, Inc.

72 employees

Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer.

Investor insights

Funding rounds participated in

$11M sweet spot round size

Investor type

Public Company

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2016

Funding rounds raised

Total raised

$11M

from investors over 1 rounds

X

Xilio Therapeutics, Inc. raised $11M on April 28, 2024

FAQ